Treatment of recurrent malignant gliomas by surgery combined with recombinant adenovirus-p53

Chinese Journal of Cancer Prevention and Treatment

Volumn 17, Issue 2, 2010, Pages 126-128

  Zhu, Jian Xin ^a   Li, Zhong Min ^a   Geng, Feng Yang ^a   Fu, Qiang ^a   Guo, Chuan Jun ^a   Xiao, Yi Lei ^a   Zhang, Zhi Ti ^a   Li, Gang ^b  

^a Liaocheng Brain Hospital   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Adenoviridae; Genes, p53; Gliomas; Neoplasm, recurrence, local; Recombination, Gentic

Indexed keywords

ADENOVIRUS VECTOR; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; PROGNOSIS; QUALITY OF LIFE; RECURRENT CANCER; SURVIVAL RATE; SURVIVAL TIME; VIRAL GENE THERAPY;

EID: 77953442641     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bourdon J C, Laurenzi V D, Melino G, et al. p53: 25 years of research and more questions to answer [J]. Cell Death Differ, 2003, 10(4):397-399.
2. Li J H, Lax S A, Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys, 1999, 43(3):607-616. (Pubitemid 29107184)
3. Bernsen H J, Rijken P F, Peters H, et al . Hypoxia in a human intracerebral glioma model [J]. J Neurosurg, 2000, 93(3):449-454.
4. Barker F C, Chang S M, Gutin P H. Survival and function status after resection of recurrent glioblastoma multiforme [J]. Neurosurgery, 1998, 42(4):709-723.
5. Vikhanskaya F, Lee M K, Mazzoletti M, et al. Cancer-derived p53 mutants suppress p532target gene exp ression-potential-mechanism for gain of function of mutant p53 [J]. Nucleic Acids Res, 2007, 35(6):2093-2104. (Pubitemid 47061674)
6. Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers [J]. Hum Gene Ther, 2005, 16(9):1016-1027. (Pubitemid 41324561)